captopril has been researched along with Acute Necrotizing Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celik, HA; Ilter, T; Nart, D; Oruc, N; Ozutemiz, O; Yuce, G | 1 |
| Chen, P; Wang, S; Xu, J; Yuan, Y; Zhan, L | 1 |
2 other study(ies) available for captopril and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target?
Topics: Amylases; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Ceruletide; Disease Models, Animal; Imidazoles; Injections, Intraperitoneal; Male; Neutrophil Infiltration; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Rats; Rats, Wistar; Renin-Angiotensin System; Taurocholic Acid; Tetrazoles; Treatment Outcome | 2010 |
Captopril, an Angiotensin-converting enzyme inhibitor, attenuates the severity of acute pancreatitis in rats by reducing expression of matrix metalloproteinase 9.
Topics: Amylases; Angiotensin-Converting Enzyme Inhibitors; Animals; Capillary Permeability; Captopril; Disease Models, Animal; Injections, Intraperitoneal; Male; Matrix Metalloproteinase 9; Oligopeptides; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2006 |